» Articles » PMID: 34201021

Glioblastoma Surgery Imaging-Reporting and Data System: Standardized Reporting of Tumor Volume, Location, and Resectability Based on Automated Segmentations

Abstract

Treatment decisions for patients with presumed glioblastoma are based on tumor characteristics available from a preoperative MR scan. Tumor characteristics, including volume, location, and resectability, are often estimated or manually delineated. This process is time consuming and subjective. Hence, comparison across cohorts, trials, or registries are subject to assessment bias. In this study, we propose a standardized Glioblastoma Surgery Imaging Reporting and Data System (GSI-RADS) based on an automated method of tumor segmentation that provides standard reports on tumor features that are potentially relevant for glioblastoma surgery. As clinical validation, we determine the agreement in extracted tumor features between the automated method and the current standard of manual segmentations from routine clinical MR scans before treatment. In an observational consecutive cohort of 1596 adult patients with a first time surgery of a glioblastoma from 13 institutions, we segmented gadolinium-enhanced tumor parts both by a human rater and by an automated algorithm. Tumor features were extracted from segmentations of both methods and compared to assess differences, concordance, and equivalence. The laterality, contralateral infiltration, and the laterality indices were in excellent agreement. The native and normalized tumor volumes had excellent agreement, consistency, and equivalence. Multifocality, but not the number of foci, had good agreement and equivalence. The location profiles of cortical and subcortical structures were in excellent agreement. The expected residual tumor volumes and resectability indices had excellent agreement, consistency, and equivalence. Tumor probability maps were in good agreement. In conclusion, automated segmentations are in excellent agreement with manual segmentations and practically equivalent regarding tumor features that are potentially relevant for neurosurgical purposes. Standard GSI-RADS reports can be generated by open access software.

Citing Articles

Sequential immunotherapy and bevacizumab treatments in glioblastoma multiforme: A case series and review of the literature.

Kertmen N, Kavgaci G, Koc I, Sagol S, Isikay A, Yazici G Oncol Lett. 2025; 29(3):146.

PMID: 39877061 PMC: 11773301. DOI: 10.3892/ol.2025.14892.


Deep Learning for MRI Segmentation and Molecular Subtyping in Glioblastoma: Critical Aspects from an Emerging Field.

Bonada M, Rossi L, Carone G, Panico F, Cofano F, Fiaschi P Biomedicines. 2024; 12(8).

PMID: 39200342 PMC: 11352020. DOI: 10.3390/biomedicines12081878.


Glioma lateralization: Focus on the anatomical localization and the distribution of molecular alterations (Review).

Tuncel Cini N, Pennisi M, Genc S, Spandidos D, Falzone L, Mitsias P Oncol Rep. 2024; 52(4).

PMID: 39155859 PMC: 11358673. DOI: 10.3892/or.2024.8798.


Augmented surgical decision-making for glioblastoma: integrating AI tools into education and practice.

Mut M, Zhang M, Gupta I, Fletcher P, Farzad F, Nwafor D Front Neurol. 2024; 15:1387958.

PMID: 38911587 PMC: 11191873. DOI: 10.3389/fneur.2024.1387958.


Standardized evaluation of the extent of resection in glioblastoma with automated early post-operative segmentation.

Luque L, Skogen K, MacIntosh B, Emblem K, Larsson C, Bouget D Front Radiol. 2024; 4:1357341.

PMID: 38840717 PMC: 11150796. DOI: 10.3389/fradi.2024.1357341.


References
1.
Rahmat R, Brochu F, Li C, Sinha R, Price S, Jena R . Semi-automated construction of patient individualised clinical target volumes for radiotherapy treatment of glioblastoma utilising diffusion tensor decomposition maps. Br J Radiol. 2020; 93(1108):20190441. PMC: 7362908. DOI: 10.1259/bjr.20190441. View

2.
Arrigo R, Boakye M, Skirboll S . Patterns of care and survival for glioblastoma patients in the Veterans population. J Neurooncol. 2011; 106(3):627-35. DOI: 10.1007/s11060-011-0702-6. View

3.
Porz N, Habegger S, Meier R, Verma R, Jilch A, Fichtner J . Fully Automated Enhanced Tumor Compartmentalization: Man vs. Machine Reloaded. PLoS One. 2016; 11(11):e0165302. PMC: 5091868. DOI: 10.1371/journal.pone.0165302. View

4.
Zinn P, Colen R, Kasper E, Burkhardt J . Extent of resection and radiotherapy in GBM: A 1973 to 2007 surveillance, epidemiology and end results analysis of 21,783 patients. Int J Oncol. 2013; 42(3):929-34. DOI: 10.3892/ijo.2013.1770. View

5.
Verburg N, Koopman T, Yaqub M, Hoekstra O, Lammertsma A, Barkhof F . Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study. Neuro Oncol. 2019; 22(3):412-422. PMC: 7058442. DOI: 10.1093/neuonc/noz180. View